1. Understanding relative survival outcomes for patients with cutaneous T-cell lymphoma (CTCL) subtypes mycosis fungoides and Sézary syndrome treated with mogamulizumab or vorinostat: combining Australian real-world evidence and MAVORIC phase 3 trial data. (October 2021) Authors: Remák, Edit; Hawkins, Neil; Jones, Trefor; Otley, Marissa; Twigger, Robert; Prince, Miles Journal: European journal of cancer Issue: Volume 156(2021)Supplement 1 Page Start: S18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pralatrexate in relapsed/refractory T-cell lymphoma: a retrospective multicenter study. Issue 2 (28th January 2021) Authors: Bhurani, Mansi; Admojo, Lorenz; Van Der Weyden, Carrie; Twigger, Robert; Bazargan, Ali; Quach, Hang; Zimet, Allan; Coyle, Luke; Lindsay, Julian; Radeski, Dejan; Hawkes, Eliza; Kennedy, Glen; Irving, Ian; Gutta, Naadir; Trotman, Judith; Yeung, James; Dunlop, Lindsay; Hua, Minh; Giri, Pratyush; Yue... Journal: Leukemia & lymphoma Issue: Volume 62:Issue 2(2021) Page Start: 330 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Quality of life in patients with mycosis fungoides and Sezary syndrome is significantly worse in female patients, Sézary syndrome and those with more extensive skin involvement. (September 2018) Authors: Molloy, Kevin; Evison, Felicity; Peng, Chenjing; Guenova, Emmanuella; Cowan, Richard; Busschots, Annemie; Woei-A-Jin, Sherida H.; Bervoets, An; Hauben, Esther; Beylot-Barry, Marie; Jonak, Constanze; Knobler, Robert; Pokert, Stefanie; Papadavid, Evangelina; Vakeva, Liisa; Matin, Rubeta; Bates, And... Journal: European journal of cancer Issue: Volume 101(2018)Supplement 1 Page Start: S39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗